Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accuracy of the Accuro 3S

NCT: NCT07458087 · NOT_YET_RECRUITING

NCT IDNCT07458087
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2028-01-15
SponsorYale University (OTHER)
First posted
Last updated

Brief Summary

The main purpose of this study is to evaluate the feasibility and accuracy of the Accuro 3S to provide live guidance when performing a neuraxial technique (e.g., spinal, or epidural). The Accuro 3S is a new device that was designed to allow for midline live neuraxial guidance. If the device can perform as the manufacturers claim the device will permit the performance of epidurals as close as doing them under fluoroscopy.

Frequently Asked Questions

What is Accuracy of the Accuro 3S?

Accuracy of the Accuro 3S is a clinical trial registered under NCT07458087. Current status: NOT_YET_RECRUITING.

What is the status of NCT07458087?

The current status of NCT07458087 (Accuracy of the Accuro 3S) is: NOT_YET_RECRUITING.

When did Accuracy of the Accuro 3S start?

Accuracy of the Accuro 3S started on 2026-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.